Dauntless Investment Group, LLC - 26 Feb 2025 SCHEDULE 13G Report for AEON Biopharma, Inc. Common (AEON)

Filing Manager: Dauntless Investment Group, LLC
Reporting Manager: Dauntless Investment Group, LLC
Security: AEON Biopharma, Inc. Common
Symbol: AEON
Shares outstanding: 1,115,711 shares
Disclosed Ownership: 108,224 shares
Ownership: 9.7%
Form type: SCHEDULE 13G
Filing time: 03 Mar 2025, 13:51:27 UTC
Date of event: 26 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Dauntless Investment Group, LLC	9.7%	108,224	0	0	/s/Matthew Okkerse	CFO